Your browser doesn't support javascript.
loading
Cytapheresis in inflammatory bowel diseases: current evidence and perspectives.
Danese, Silvio; Angelucci, Erika; Stefanelli, Tommaso; Omodei, Paolo; Luigiano, Carmelo; Finazzi, Silvia; Pagano, Nico; Repici, Alessandro; Vecchi, Maurizio; Malesci, Alberto.
Afiliação
  • Danese S; Division of Gastroenterology, Istituto Clinico Humanitas, IRCCS in Gastroenterology, University of Milan, Rozzano/Milan, Italy. sdanese@hotmail.com
Digestion ; 77(2): 96-107, 2008.
Article em En | MEDLINE | ID: mdl-18382085
Ulcerative colitis and Crohn's disease are inflammatory bowel diseases with a chronic relapsing course. Management of both conditions is far from being fully satisfactory. For this reason in the last decade a large number of biological therapies, targeting cytokines involved in intestinal inflammation, has been developed with various results in terms of efficacy, safety and costs. Activated granulocytes and monocytes represent the major sources of pro-inflammatory cytokines in the intestinal mucosa, playing a pivotal role in inducing and maintaining intestinal inflammation. Leukocytapheresis using an adsorptive carrier-based system (Adacolumn) or a removal filter column (Cellsorba) has been proposed as a feasible, safe and effective therapy for ulcerative colitis and Crohn's disease. The objective of this paper is to provide an overview on the current knowledge about mechanisms of action, available clinical data and the possible future perspectives for the use of Adacolumn and Cellsorba in the management of inflammatory bowel diseases.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Doença de Crohn / Citaferese Limite: Humans Idioma: En Ano de publicação: 2008 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Doença de Crohn / Citaferese Limite: Humans Idioma: En Ano de publicação: 2008 Tipo de documento: Article